<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>endometrial cancer &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/endometrial-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 08 Oct 2026 01:31:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>endometrial cancer &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Radiotherapy Still Matters in dMMR Endometrial Cancer, Researchers Warn in the Immunotherapy Era</title>
		<link>https://bioengineer.org/radiotherapy-still-matters-in-dmmr-endometrial-cancer-researchers-warn-in-the-immunotherapy-era/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Thu, 08 Oct 2026 01:31:32 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[dMMR]]></category>
		<category><![CDATA[endometrial cancer]]></category>
		<category><![CDATA[ESGO-ESTRO-ESP guidelines]]></category>
		<category><![CDATA[GOG-258]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[KEYNOTE-B21]]></category>
		<category><![CDATA[locoregional control]]></category>
		<category><![CDATA[molecular classification]]></category>
		<category><![CDATA[pembrolizumab)]]></category>
		<category><![CDATA[PORTEC-3]]></category>
		<category><![CDATA[Radiotherapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=406620</guid>

					<description><![CDATA[A new Viewpoint in eClinicalMedicine argues that immune checkpoint inhibitors have not yet proven they can replace pelvic radiotherapy in completely resected stage III dMMR endometrial cancer, urging caution against treatment de-escalation.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">406620</post-id>	</item>
	</channel>
</rss>
